UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 166 filers reported holding UNIQURE NV in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $340,104 | -64.5% | 50,686 | +6.5% | 0.00% | – |
| Q2 2023 | $958,845 | 0.0% | 47,609 | 0.0% | 0.00% | – |
| Q1 2023 | $958,845 | +21.6% | 47,609 | +36.9% | 0.00% | – |
| Q4 2022 | $788,327 | -99.9% | 34,774 | +2.7% | 0.00% | – |
| Q3 2022 | $635,083,000 | +20.3% | 33,853 | +19.5% | 0.00% | – |
| Q2 2022 | $527,885,000 | +3.2% | 28,320 | 0.0% | 0.00% | – |
| Q1 2022 | $511,741,000 | -11.4% | 28,320 | +1.7% | 0.00% | – |
| Q4 2021 | $577,464,000 | -31.2% | 27,843 | +6.1% | 0.00% | – |
| Q3 2021 | $839,942,000 | +5.5% | 26,240 | +1.5% | 0.00% | – |
| Q2 2021 | $796,303,000 | -28.6% | 25,854 | -22.0% | 0.00% | – |
| Q1 2021 | $1,116,049,000 | -6.8% | 33,127 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $1,196,879,000 | -94.6% | 33,127 | -94.5% | 0.00% | -91.7% |
| Q3 2020 | $22,072,145,000 | -51.3% | 599,298 | -40.4% | 0.01% | -57.1% |
| Q2 2020 | $45,314,994,000 | +32.2% | 1,005,659 | +39.2% | 0.03% | +12.0% |
| Q1 2020 | $34,278,640,000 | -16.9% | 722,416 | +25.5% | 0.02% | 0.0% |
| Q4 2019 | $41,263,692,000 | +352.8% | 575,826 | +148.7% | 0.02% | +316.7% |
| Q3 2019 | $9,113,808,000 | -46.0% | 231,550 | +7.3% | 0.01% | -50.0% |
| Q2 2019 | $16,863,207,000 | +1809.4% | 215,780 | +1357.4% | 0.01% | +1100.0% |
| Q1 2019 | $883,178,000 | +226.2% | 14,806 | +57.6% | 0.00% | – |
| Q4 2018 | $270,735,000 | +16.2% | 9,394 | +46.8% | 0.00% | – |
| Q3 2018 | $232,896,000 | +9186.1% | 6,400 | -98.0% | 0.00% | -100.0% |
| Q3 2016 | $2,508,000 | +2.5% | 327,809 | -1.3% | 0.00% | 0.0% |
| Q2 2016 | $2,448,000 | -40.3% | 332,209 | -3.8% | 0.00% | -40.0% |
| Q1 2016 | $4,103,000 | -24.0% | 345,403 | +5.8% | 0.01% | -16.7% |
| Q4 2015 | $5,402,000 | -19.1% | 326,600 | 0.0% | 0.01% | -14.3% |
| Q3 2015 | $6,679,000 | -24.3% | 326,600 | 0.0% | 0.01% | -12.5% |
| Q2 2015 | $8,818,000 | +1397.1% | 326,600 | +761.7% | 0.01% | +700.0% |
| Q1 2014 | $589,000 | – | 37,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |